Drug intelligence / Profile preview

cloprednol

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Cloprednol is a synthetic glucocorticoid, classified as a small molecule drug. It has been investigated primarily for the treatment of asthma and arthritis. As a glucocorticoid, cloprednol acts as an agonist at the glucocorticoid receptor, exerting anti-inflammatory and immunosuppressive effects by modulating gene expression to inhibit pro-inflammatory signals and promote anti-inflammatory pathways. Clinical studies have shown that oral cloprednol can improve control in corticosteroid-dependent asthma with fewer long-term side effects compared to other corticosteroids[1][4][5]. Its pharmacokinetics are characterized by a short serum half-life (approximately 1.8–2.7 hours), nonlinear plasma protein binding, and rapid onset of action[4][6]. The drug has also been used topically for localized inflammatory conditions such as eczema[2].

Brand names
CloradrynNovacortSyntestan
Other names
CloprednolumCloprednol [usan:inn:ban]Cloprednol [inn]Cloprednol (usan/inn)Unii-syp56o3gjgUnii-syp-56o3gjgUnii-syp 56o3gjg
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on cloprednol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cloprednol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call